Turnkey Plant Designed to Budg.

Plant Contracting for the Pharmaceutical Industry

01.06.2001 Meistgelesen zum Thema Ans Licht gebracht Fettbestimmung in Lebens- und Futtermittelnin der pflicht Mikrobiologische Richtwerte für LebensmittelverpackungenMegaprojekt: dem Standort verpflichtet Roche baut Diagnostika-Produktion in Penzberg ausWeit mehr als nur Papier GMP in Pharma, Food und KosmetikKomplexer Mikrokosmos P+F Trendbericht Anlagenbau Whilst turnkey plants are nothing new to the chemical industry, in the past this model

Anzeige

Whilst turnkey plants are nothing new to the chemical industry, in the past
this model was not very common in the pharmaceutical industry. However,
increasing time and cost constraints are changing the situation. For the
construction of both biotechnological and active-ingredients plants, general
contractors are increasingly taking overall responsibility. „Design-to-budget“
is the new formula assuring worldwide customer satisfaction in the
pharmaceutical industry. Two out-standing
projects presently being executed in Europe by Lurgi Life
Science GmbH (Germany) are the multi-product plants for Boehringer
Ingelheim Pharma KG (Germany) and Rohner AG (Switzerland).

Heftausgabe: International (englisch) 2000
Anzeige
Loader-Icon